The evolution of and risk factors for neck muscle atrophy and weakness in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy: A retrospective study in an endemic area

Medicine (United States)

Volumn 94, Issue 31, 2015, Pages

  Zhang, Lu Lu ^a   Mao, Yan Ping ^a   Zhou, Guan Qun ^a   Tang, Ling Long ^a   Qi, Zhen Yu ^a   Lin, Li ^a   Yao, Ji Jin ^a   Ma, Jun ^a   Lin, Ai Hua ^a   Sun, Ying ^a   Xie, Maohua ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; FEMALE; FOLLOW UP; HEAD AND NECK DISEASE; HUMAN; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; MUSCLE ATROPHY; MUSCLE WEAKNESS; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEX DIFFERENCE; STERNOCLEIDOMASTOID MUSCLE; WEIGHT CHANGE; ADOLESCENT; ADVERSE EFFECTS; CHINA; ENDEMIC DISEASE; MIDDLE AGED; MUSCULAR ATROPHY; NASOPHARYNGEAL NEOPLASMS; NECK MUSCLE; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHINA; ENDEMIC DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE WEAKNESS; MUSCULAR ATROPHY; NASOPHARYNGEAL NEOPLASMS; NECK MUSCLES; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84942418206     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001294     Document Type: Article

References (33)

1. Chan AT, Teo PM, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol. 2002; 13: 1007-1015.
2. Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003; 69: 227-236.
3. Powers BE, Gillette EL, Gillette SL, et al. Muscle injury following experimental intraoperative irradiation. Int J Radiat Oncol Biol Phys. 1991; 20: 463-471.
4. Gillette BL, Mahler PA, Powers BE, et al. Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys. 1995; 31: 1309-1318.
5. Nichol AM, Smith SL, D'yachkova Y, et al. Quantification of masticatory muscle atrophy after high-dose radiotherapy. Int J Radiat Oncol Biol Phys. 2003; 56: 1170-1179.
6. Ghosh PS, Milone M. Clinical and laboratory findings of 21 patients with radiation-induced myopathy. J Neurol Neurosurg Psychiatry. 2015; 86: 152-158.
7. Van Leeuwen-Segarceanu EM, Dorresteijn LD, Pillen S, et al. Progressive muscle atrophy and weakness after treatment by mantle field radiotherapy in Hodgkin lymphoma survivors. Int J Radiat Oncol Biol Phys. 2012; 82: 612-618.
8. Saarilahti K, Kouri M, Collan J, et al. Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol. 2005; 74: 251-258.
9. Blouin JS, Siegmund GP, Carpenter MG, et al. Neural control of superficial and deep neck muscles in humans. J Neurophysiol. 2007; 98: 920-928.
10. Lim HK, Hong SH, Yoo HJ, et al. Visual MRI grading system to evaluate atrophy of the supraspinatus muscle. Korean J Radiol. 2014; 15: 501-507.
11. Tingart MJ, Apreleva M, Lehtinen JT, et al. Magnetic resonance imaging in quantitative analysis of rotator cuff muscle volume. Clin Orthop Relat Res. 2003; 415: 104-110.
12. Al-Saleh MA, Jaremko JL, Saltaji H, et al. MRI findings of radiation-induced changes of masticatory muscles: a systematic review. J Otolaryngol Head Neck Surg. 2013; 42: 26.
13. Cuccia G, Shelley OP, d'Alcontres FS, et al. Evidence of significant sternocleidomastoid atrophy following modified radical neck dissection type III. Plast Reconstr Surg. 2006; 117: 227-232.
14. Delanian S1, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004; 73: 119-131.
15. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010; 17: 1471-1474.
16. Pavy JJ, Denekamp J, Letschert J, et al. EORTC Late Effects Working Group. Late effects toxicity scoring: the SOMA scale. Radiother Oncol. 1995; 35: 11-15.
17. Zhang H, Lu N, Feng C, et al. On fitting generalized linear mixed-effects models for binary responses using different statistical packages. Stat Med. 2011; 30: 2562-2572.
18. Wilke DR, Krahn M, Tomlinson G, et al. Sex or survival: short-term versus long-term androgen deprivation in patients with locally advanced prostate cancer treated with radiotherapy. Cancer. 2010; 116: 1909-1917.
19. Panjabi M, Malcolmson G, Teng E, et al. Hybrid testing of lumbar CHARITE discs versus fusions. Spine (Phila Pa 1976). 2007; 32: 959-966.
20. Xin M, Li R, Xie M, et al. Small-molecule Bax agonists for cancer therapy. Nat Commun. 2014; 5: 4935.
21. Rubin P, Casarett GW. Clinical radiation pathology. Cancer. 1968; 22: 767-778.
22. Popovtzer A, Cao Y, Feng FY, et al. Anatomical changes in the pharyngeal constrictors after chemo-irradiation of head and neck cancer and their dose-effect relationships: MRI-based study. Radiother Oncol. 2009; 93: 510-515.
23. Welsh JS, Torre TG, DeWeese TL, et al. Radiation myositis. Ann Oncol. 1999; 10: 1105-1108.
24. Alameddine HS, Dehaupas M, Fardeau M. Regeneration of skeletal muscle fibers from autologous satellite cells multiplied in vitro. An experimental model for testing cultured cell myogenicity. Muscle Nerve. 1989; 12: 544-555.
25. Fajardo LF, Berthrong M. Vascular lesions following radiation. Pathol Annu. 1988; 23 (pt 1): 297-330.
26. Ho FC, Tham IW, Earnest A, et al. Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer. 2012; 12: 98.
27. Gregoire V, Ang K, Budach W, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014; 110: 172-181.
28. Adelstein DJ, Lavertu P, Saxton JP, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer. 2000; 88: 876-883.
29. Bonifati DM, Ori C, Rossi CR, et al. Neuromuscular damage after hyperthermic isolated limb perfusion in patients with melanoma or sarcoma treated with chemotherapeutic agents. Cancer Chemother Pharmacol. 2000; 46: 517-522.
30. Studenski SA, Peters KW, Alley DE, et al. The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates. J Gerontol A Biol Sci Med Sci. 2014; 69: 547-548.
31. Kontos CK, Fendri A, Khabir A, et al. Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study. BMC Cancer. 2013; 13: 293.
32. He JH, Liao XL, Wang W, et al. Apogossypolone, a small-molecule inhibitor of Bcl-2, induces radiosensitization of nasopharyngeal carcinoma cells by stimulating autophagy. Int J Oncol. 2014; 45: 1099-1108.
33. Vaillant F, Merino D, Lee L, et al. Targeting BCL-2 with the BH3 mimetic ABT-199 in estrogen receptor-positive breast cancer. Cancer Cell. 2013; 24: 120-129.